TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Oral Vaccine for Human Market, Global Outlook and Forecast 2025-2030

Oral Vaccine for Human Market, Global Outlook and Forecast 2025-2030

  • Category:Life Sciences
  • Published on : 03 January 2025
  • Pages :
  • Formats:
  • Report Code:SMR-8026344
OfferClick for best price

Best Price: $2600

Oral Vaccine for Human Market Size, Share 2025


Report Overview

Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.

The global Oral Vaccine for Human market size was estimated at USD 2540 million in 2023 and is projected to reach USD 4183.20 million by 2032, exhibiting a CAGR of 5.70% during the forecast period.

North America Oral Vaccine for Human market size was estimated at USD 728.10 million in 2023, at a CAGR of 4.89% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Oral Vaccine for Human market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oral Vaccine for Human Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oral Vaccine for Human market in any manner.

Global Oral Vaccine for Human Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Market Segmentation (by Type)

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Other

Market Segmentation (by Application)

Public

Private

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Oral Vaccine for Human Market

Overview of the regional outlook of the Oral Vaccine for Human Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oral Vaccine for Human Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Oral Vaccine for Human, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Report Attributes Report Details
Report Title Oral Vaccine for Human Market, Global Outlook and Forecast 2025-2030
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2024
Forecast Year 2032
Number of Pages NA Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oral Vaccine for Human
1.2 Key Market Segments
1.2.1 Oral Vaccine for Human Segment by Type
1.2.2 Oral Vaccine for Human Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oral Vaccine for Human Market Overview
2.1 Global Market Overview
2.1.1 Global Oral Vaccine for Human Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oral Vaccine for Human Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oral Vaccine for Human Market Competitive Landscape
3.1 Global Oral Vaccine for Human Sales by Manufacturers (2019-2024)
3.2 Global Oral Vaccine for Human Revenue Market Share by Manufacturers (2019-2024)
3.3 Oral Vaccine for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oral Vaccine for Human Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oral Vaccine for Human Sales Sites, Area Served, Product Type
3.6 Oral Vaccine for Human Market Competitive Situation and Trends
3.6.1 Oral Vaccine for Human Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Vaccine for Human Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oral Vaccine for Human Industry Chain Analysis
4.1 Oral Vaccine for Human Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oral Vaccine for Human Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oral Vaccine for Human Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Vaccine for Human Sales Market Share by Type (2019-2024)
6.3 Global Oral Vaccine for Human Market Size Market Share by Type (2019-2024)
6.4 Global Oral Vaccine for Human Price by Type (2019-2024)
7 Oral Vaccine for Human Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Vaccine for Human Market Sales by Application (2019-2024)
7.3 Global Oral Vaccine for Human Market Size (M USD) by Application (2019-2024)
7.4 Global Oral Vaccine for Human Sales Growth Rate by Application (2019-2024)
8 Oral Vaccine for Human Market Consumption by Region
8.1 Global Oral Vaccine for Human Sales by Region
8.1.1 Global Oral Vaccine for Human Sales by Region
8.1.2 Global Oral Vaccine for Human Sales Market Share by Region
8.2 North America
8.2.1 North America Oral Vaccine for Human Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oral Vaccine for Human Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oral Vaccine for Human Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oral Vaccine for Human Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oral Vaccine for Human Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Oral Vaccine for Human Market Production by Region
9.1 Global Production of Oral Vaccine for Human by Region (2019-2024)
9.2 Global Oral Vaccine for Human Revenue Market Share by Region (2019-2024)
9.3 Global Oral Vaccine for Human Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Oral Vaccine for Human Production
9.4.1 North America Oral Vaccine for Human Production Growth Rate (2019-2024)
9.4.2 North America Oral Vaccine for Human Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Oral Vaccine for Human Production
9.5.1 Europe Oral Vaccine for Human Production Growth Rate (2019-2024)
9.5.2 Europe Oral Vaccine for Human Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Oral Vaccine for Human Production (2019-2024)
9.6.1 Japan Oral Vaccine for Human Production Growth Rate (2019-2024)
9.6.2 Japan Oral Vaccine for Human Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Oral Vaccine for Human Production (2019-2024)
9.7.1 China Oral Vaccine for Human Production Growth Rate (2019-2024)
9.7.2 China Oral Vaccine for Human Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck Oral Vaccine for Human Basic Information
10.1.2 Merck Oral Vaccine for Human Product Overview
10.1.3 Merck Oral Vaccine for Human Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Oral Vaccine for Human SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Oral Vaccine for Human Basic Information
10.2.2 GSK Oral Vaccine for Human Product Overview
10.2.3 GSK Oral Vaccine for Human Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Oral Vaccine for Human SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Oral Vaccine for Human Basic Information
10.3.2 Sanofi Oral Vaccine for Human Product Overview
10.3.3 Sanofi Oral Vaccine for Human Product Market Performance
10.3.4 Sanofi Oral Vaccine for Human SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Oral Vaccine for Human Basic Information
10.4.2 Lanzhou Institute Oral Vaccine for Human Product Overview
10.4.3 Lanzhou Institute Oral Vaccine for Human Product Market Performance
10.4.4 Lanzhou Institute Business Overview
10.4.5 Lanzhou Institute Recent Developments
10.5 Serum Institute
10.5.1 Serum Institute Oral Vaccine for Human Basic Information
10.5.2 Serum Institute Oral Vaccine for Human Product Overview
10.5.3 Serum Institute Oral Vaccine for Human Product Market Performance
10.5.4 Serum Institute Business Overview
10.5.5 Serum Institute Recent Developments
10.6 Valneva
10.6.1 Valneva Oral Vaccine for Human Basic Information
10.6.2 Valneva Oral Vaccine for Human Product Overview
10.6.3 Valneva Oral Vaccine for Human Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Oral Vaccine for Human Basic Information
10.7.2 Shanghai United Cell Oral Vaccine for Human Product Overview
10.7.3 Shanghai United Cell Oral Vaccine for Human Product Market Performance
10.7.4 Shanghai United Cell Business Overview
10.7.5 Shanghai United Cell Recent Developments
10.8 Bibcol
10.8.1 Bibcol Oral Vaccine for Human Basic Information
10.8.2 Bibcol Oral Vaccine for Human Product Overview
10.8.3 Bibcol Oral Vaccine for Human Product Market Performance
10.8.4 Bibcol Business Overview
10.8.5 Bibcol Recent Developments
10.9 PaxVax
10.9.1 PaxVax Oral Vaccine for Human Basic Information
10.9.2 PaxVax Oral Vaccine for Human Product Overview
10.9.3 PaxVax Oral Vaccine for Human Product Market Performance
10.9.4 PaxVax Business Overview
10.9.5 PaxVax Recent Developments
10.10 Vabiotech
10.10.1 Vabiotech Oral Vaccine for Human Basic Information
10.10.2 Vabiotech Oral Vaccine for Human Product Overview
10.10.3 Vabiotech Oral Vaccine for Human Product Market Performance
10.10.4 Vabiotech Business Overview
10.10.5 Vabiotech Recent Developments
10.11 Tiantan Biological
10.11.1 Tiantan Biological Oral Vaccine for Human Basic Information
10.11.2 Tiantan Biological Oral Vaccine for Human Product Overview
10.11.3 Tiantan Biological Oral Vaccine for Human Product Market Performance
10.11.4 Tiantan Biological Business Overview
10.11.5 Tiantan Biological Recent Developments
10.12 EuBiologics
10.12.1 EuBiologics Oral Vaccine for Human Basic Information
10.12.2 EuBiologics Oral Vaccine for Human Product Overview
10.12.3 EuBiologics Oral Vaccine for Human Product Market Performance
10.12.4 EuBiologics Business Overview
10.12.5 EuBiologics Recent Developments
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Oral Vaccine for Human Basic Information
10.13.2 Panacea Biotec Ltd Oral Vaccine for Human Product Overview
10.13.3 Panacea Biotec Ltd Oral Vaccine for Human Product Market Performance
10.13.4 Panacea Biotec Ltd Business Overview
10.13.5 Panacea Biotec Ltd Recent Developments
10.14 Bio-Med
10.14.1 Bio-Med Oral Vaccine for Human Basic Information
10.14.2 Bio-Med Oral Vaccine for Human Product Overview
10.14.3 Bio-Med Oral Vaccine for Human Product Market Performance
10.14.4 Bio-Med Business Overview
10.14.5 Bio-Med Recent Developments
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Basic Information
10.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product Overview
10.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product Market Performance
10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 Oral Vaccine for Human Market Forecast by Region
11.1 Global Oral Vaccine for Human Market Size Forecast
11.2 Global Oral Vaccine for Human Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oral Vaccine for Human Market Size Forecast by Country
11.2.3 Asia Pacific Oral Vaccine for Human Market Size Forecast by Region
11.2.4 South America Oral Vaccine for Human Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oral Vaccine for Human by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Oral Vaccine for Human Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oral Vaccine for Human by Type (2025-2032)
12.1.2 Global Oral Vaccine for Human Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oral Vaccine for Human by Type (2025-2032)
12.2 Global Oral Vaccine for Human Market Forecast by Application (2025-2032)
12.2.1 Global Oral Vaccine for Human Sales (K MT) Forecast by Application
12.2.2 Global Oral Vaccine for Human Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oral Vaccine for Human Market Size Comparison by Region (M USD)
Table 5. Global Oral Vaccine for Human Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Oral Vaccine for Human Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oral Vaccine for Human Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oral Vaccine for Human Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccine for Human as of 2022)
Table 10. Global Market Oral Vaccine for Human Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oral Vaccine for Human Sales Sites and Area Served
Table 12. Manufacturers Oral Vaccine for Human Product Type
Table 13. Global Oral Vaccine for Human Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oral Vaccine for Human
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oral Vaccine for Human Market Challenges
Table 22. Global Oral Vaccine for Human Sales by Type (K MT)
Table 23. Global Oral Vaccine for Human Market Size by Type (M USD)
Table 24. Global Oral Vaccine for Human Sales (K MT) by Type (2019-2024)
Table 25. Global Oral Vaccine for Human Sales Market Share by Type (2019-2024)
Table 26. Global Oral Vaccine for Human Market Size (M USD) by Type (2019-2024)
Table 27. Global Oral Vaccine for Human Market Size Share by Type (2019-2024)
Table 28. Global Oral Vaccine for Human Price (USD/MT) by Type (2019-2024)
Table 29. Global Oral Vaccine for Human Sales (K MT) by Application
Table 30. Global Oral Vaccine for Human Market Size by Application
Table 31. Global Oral Vaccine for Human Sales by Application (2019-2024) & (K MT)
Table 32. Global Oral Vaccine for Human Sales Market Share by Application (2019-2024)
Table 33. Global Oral Vaccine for Human Sales by Application (2019-2024) & (M USD)
Table 34. Global Oral Vaccine for Human Market Share by Application (2019-2024)
Table 35. Global Oral Vaccine for Human Sales Growth Rate by Application (2019-2024)
Table 36. Global Oral Vaccine for Human Sales by Region (2019-2024) & (K MT)
Table 37. Global Oral Vaccine for Human Sales Market Share by Region (2019-2024)
Table 38. North America Oral Vaccine for Human Sales by Country (2019-2024) & (K MT)
Table 39. Europe Oral Vaccine for Human Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Oral Vaccine for Human Sales by Region (2019-2024) & (K MT)
Table 41. South America Oral Vaccine for Human Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Oral Vaccine for Human Sales by Region (2019-2024) & (K MT)
Table 43. Global Oral Vaccine for Human Production (K MT) by Region (2019-2024)
Table 44. Global Oral Vaccine for Human Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Oral Vaccine for Human Revenue Market Share by Region (2019-2024)
Table 46. Global Oral Vaccine for Human Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Oral Vaccine for Human Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Oral Vaccine for Human Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Oral Vaccine for Human Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Oral Vaccine for Human Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merck Oral Vaccine for Human Basic Information
Table 52. Merck Oral Vaccine for Human Product Overview
Table 53. Merck Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck Oral Vaccine for Human SWOT Analysis
Table 56. Merck Recent Developments
Table 57. GSK Oral Vaccine for Human Basic Information
Table 58. GSK Oral Vaccine for Human Product Overview
Table 59. GSK Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. GSK Business Overview
Table 61. GSK Oral Vaccine for Human SWOT Analysis
Table 62. GSK Recent Developments
Table 63. Sanofi Oral Vaccine for Human Basic Information
Table 64. Sanofi Oral Vaccine for Human Product Overview
Table 65. Sanofi Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sanofi Oral Vaccine for Human SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Lanzhou Institute Oral Vaccine for Human Basic Information
Table 70. Lanzhou Institute Oral Vaccine for Human Product Overview
Table 71. Lanzhou Institute Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Lanzhou Institute Business Overview
Table 73. Lanzhou Institute Recent Developments
Table 74. Serum Institute Oral Vaccine for Human Basic Information
Table 75. Serum Institute Oral Vaccine for Human Product Overview
Table 76. Serum Institute Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Serum Institute Business Overview
Table 78. Serum Institute Recent Developments
Table 79. Valneva Oral Vaccine for Human Basic Information
Table 80. Valneva Oral Vaccine for Human Product Overview
Table 81. Valneva Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Valneva Business Overview
Table 83. Valneva Recent Developments
Table 84. Shanghai United Cell Oral Vaccine for Human Basic Information
Table 85. Shanghai United Cell Oral Vaccine for Human Product Overview
Table 86. Shanghai United Cell Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Shanghai United Cell Business Overview
Table 88. Shanghai United Cell Recent Developments
Table 89. Bibcol Oral Vaccine for Human Basic Information
Table 90. Bibcol Oral Vaccine for Human Product Overview
Table 91. Bibcol Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Bibcol Business Overview
Table 93. Bibcol Recent Developments
Table 94. PaxVax Oral Vaccine for Human Basic Information
Table 95. PaxVax Oral Vaccine for Human Product Overview
Table 96. PaxVax Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. PaxVax Business Overview
Table 98. PaxVax Recent Developments
Table 99. Vabiotech Oral Vaccine for Human Basic Information
Table 100. Vabiotech Oral Vaccine for Human Product Overview
Table 101. Vabiotech Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Vabiotech Business Overview
Table 103. Vabiotech Recent Developments
Table 104. Tiantan Biological Oral Vaccine for Human Basic Information
Table 105. Tiantan Biological Oral Vaccine for Human Product Overview
Table 106. Tiantan Biological Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Tiantan Biological Business Overview
Table 108. Tiantan Biological Recent Developments
Table 109. EuBiologics Oral Vaccine for Human Basic Information
Table 110. EuBiologics Oral Vaccine for Human Product Overview
Table 111. EuBiologics Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. EuBiologics Business Overview
Table 113. EuBiologics Recent Developments
Table 114. Panacea Biotec Ltd Oral Vaccine for Human Basic Information
Table 115. Panacea Biotec Ltd Oral Vaccine for Human Product Overview
Table 116. Panacea Biotec Ltd Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Panacea Biotec Ltd Business Overview
Table 118. Panacea Biotec Ltd Recent Developments
Table 119. Bio-Med Oral Vaccine for Human Basic Information
Table 120. Bio-Med Oral Vaccine for Human Product Overview
Table 121. Bio-Med Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Bio-Med Business Overview
Table 123. Bio-Med Recent Developments
Table 124. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Basic Information
Table 125. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product Overview
Table 126. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Halfkin Bio-Pharmaceuticals Business Overview
Table 128. Halfkin Bio-Pharmaceuticals Recent Developments
Table 129. Global Oral Vaccine for Human Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Oral Vaccine for Human Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Oral Vaccine for Human Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Oral Vaccine for Human Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Oral Vaccine for Human Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Oral Vaccine for Human Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Oral Vaccine for Human Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Oral Vaccine for Human Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Oral Vaccine for Human Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Oral Vaccine for Human Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Oral Vaccine for Human Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Oral Vaccine for Human Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Oral Vaccine for Human Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Oral Vaccine for Human Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Oral Vaccine for Human Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Oral Vaccine for Human Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Oral Vaccine for Human Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Oral Vaccine for Human
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oral Vaccine for Human Market Size (M USD), 2019-2032
Figure 5. Global Oral Vaccine for Human Market Size (M USD) (2019-2032)
Figure 6. Global Oral Vaccine for Human Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oral Vaccine for Human Market Size by Country (M USD)
Figure 11. Oral Vaccine for Human Sales Share by Manufacturers in 2023
Figure 12. Global Oral Vaccine for Human Revenue Share by Manufacturers in 2023
Figure 13. Oral Vaccine for Human Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oral Vaccine for Human Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oral Vaccine for Human Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oral Vaccine for Human Market Share by Type
Figure 18. Sales Market Share of Oral Vaccine for Human by Type (2019-2024)
Figure 19. Sales Market Share of Oral Vaccine for Human by Type in 2023
Figure 20. Market Size Share of Oral Vaccine for Human by Type (2019-2024)
Figure 21. Market Size Market Share of Oral Vaccine for Human by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oral Vaccine for Human Market Share by Application
Figure 24. Global Oral Vaccine for Human Sales Market Share by Application (2019-2024)
Figure 25. Global Oral Vaccine for Human Sales Market Share by Application in 2023
Figure 26. Global Oral Vaccine for Human Market Share by Application (2019-2024)
Figure 27. Global Oral Vaccine for Human Market Share by Application in 2023
Figure 28. Global Oral Vaccine for Human Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oral Vaccine for Human Sales Market Share by Region (2019-2024)
Figure 30. North America Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Oral Vaccine for Human Sales Market Share by Country in 2023
Figure 32. U.S. Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Oral Vaccine for Human Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Oral Vaccine for Human Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Oral Vaccine for Human Sales Market Share by Country in 2023
Figure 37. Germany Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Oral Vaccine for Human Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Oral Vaccine for Human Sales Market Share by Region in 2023
Figure 44. China Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Oral Vaccine for Human Sales and Growth Rate (K MT)
Figure 50. South America Oral Vaccine for Human Sales Market Share by Country in 2023
Figure 51. Brazil Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Oral Vaccine for Human Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Oral Vaccine for Human Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Oral Vaccine for Human Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Oral Vaccine for Human Production Market Share by Region (2019-2024)
Figure 62. North America Oral Vaccine for Human Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Oral Vaccine for Human Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Oral Vaccine for Human Production (K MT) Growth Rate (2019-2024)
Figure 65. China Oral Vaccine for Human Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Oral Vaccine for Human Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Oral Vaccine for Human Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Oral Vaccine for Human Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Oral Vaccine for Human Market Share Forecast by Type (2025-2032)
Figure 70. Global Oral Vaccine for Human Sales Forecast by Application (2025-2032)
Figure 71. Global Oral Vaccine for Human Market Share Forecast by Application (2025-2032)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount